Eckert & Ziegler SE (ETR:EUZ)
15.59
+0.14 (0.91%)
Apr 17, 2026, 5:35 PM CET
Eckert & Ziegler SE Revenue
In the year 2025, Eckert & Ziegler SE had annual revenue of 311.96M EUR with 5.45% growth. Eckert & Ziegler SE had revenue of 87.84M in the quarter ending December 31, 2025, with 9.32% growth.
Revenue
311.96M
Revenue Growth
+5.45%
P/S Ratio
3.13
Revenue / Employee
279.53K
Employees
1,116
Market Cap
975.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 311.96M | 16.11M | 5.45% |
| Dec 31, 2024 | 295.85M | 49.76M | 20.22% |
| Dec 31, 2023 | 246.09M | 23.86M | 10.74% |
| Dec 31, 2022 | 222.23M | 41.79M | 23.16% |
| Dec 31, 2021 | 180.44M | 4.30M | 2.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.87B |
| Merck KGaA | 21.10B |
| Drägerwerk AG & Co. KGaA | 3.48B |
| Redcare Pharmacy NV | 2.94B |
| Gerresheimer AG | 2.25B |
| Carl Zeiss Meditec AG | 2.20B |
Eckert & Ziegler SE News
- 6 days ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 22 days ago - Q4 2025 Eckert & Ziegler SE Earnings Call Transcript - GuruFocus
- 26 days ago - EQS-DD: Eckert & Ziegler SE: Dr. Gunnar Mann, Allocation of 12,545 shares as part of executive board remuneration (own shares of the issuer). This is a share-based remuneration with an automatic ... - Wallstreet:Online
- 26 days ago - EQS-DD: Eckert & Ziegler SE: Dr. Harald Hasselmann, Allocation of 62,541 shares as part of executive board remuneration (own shares of the issuer). This is a share-based remuneration with an ... - Wallstreet:Online
- 5 weeks ago - EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 6 weeks ago - EQS-Adhoc: Eckert & Ziegler Plans Dividend of € 0.22 per Share for 2025 - Wallstreet:Online
- 7 weeks ago - EQS-AFR: Eckert & Ziegler SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - Wallstreet:Online
- 7 weeks ago - EQS-AFR: Eckert & Ziegler SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online